Table 2.
Patient and treatment characteristics (n = 95)
| Feature | Number | Percentage |
|---|---|---|
| Sex |
|
|
| Male |
52 |
55% |
| Female |
43 |
45% |
| Age |
|
|
| Median |
55 |
|
| Range |
19-77 |
|
| Tumor |
|
|
| Unifocal |
85 |
89% |
| Multifocal |
10 |
11% |
| Surgery |
|
|
| Biopsy only |
13 |
14% |
| STR |
50 |
56% |
| GTR |
27 |
30% |
| Radiation |
|
|
| 60 Gy |
92 |
97% |
| <60 Gy |
3 |
3% |
| Adjuvant TMZ |
|
|
| Concurrent TMZ |
95 |
100% |
| Received post-RT TMZ |
83 |
87% |
| Did not receive post-RT TMZ |
12 |
13% |
| Median cycles |
6 |
|
| Range of cycles | 0-26 |
Abbreviations:GTR Gross tumor resection, STR sub-total resection, TMZ temozolomide.